0001209191-24-002740.txt : 20240205
0001209191-24-002740.hdr.sgml : 20240205
20240205060015
ACCESSION NUMBER: 0001209191-24-002740
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240205
DATE AS OF CHANGE: 20240205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sabella Lauren M
CENTRAL INDEX KEY: 0001360928
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50865
FILM NUMBER: 24593788
MAIL ADDRESS:
STREET 1: C/O ACORDA THERAPEUTICS
STREET 2: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MANNKIND CORP
CENTRAL INDEX KEY: 0000899460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 133607736
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CASPER STREET
CITY: DANBURY
STATE: CT
ZIP: 06810
BUSINESS PHONE: 818-661-5000
MAIL ADDRESS:
STREET 1: 1 CASPER STREET
CITY: DANBURY
STATE: CT
ZIP: 06810
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-31
0
0000899460
MANNKIND CORP
MNKD
0001360928
Sabella Lauren M
1 CASPER STREET
DANBURY
CT
06810
0
1
0
0
EVP Chief Operating Officer
0
Common Stock, $0.01 Par Value
2023-12-31
4
A
0
711
3.09
A
248145
D
Common Stock, $0.01 Par Value
2024-02-04
4
A
0
15290
3.27
A
263435
D
Includes 711 shares of common stock purchased under the Company's Employee Stock Purchase Plan on December 31, 2023 in an exempt transaction.
The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective May 13, 2023. The purchase was approved by the Company's Board of Directors on February 4, 2024.
/s/ Lauren Sabella
2024-02-05